RxDoctor Payments DataLook up a doctor →

Shannon Hallman

Adult Health · West Columbia, SCNPI 1528133915

Payments from drug & device makers

$7,323in general payments, 2019–2025

Across 274 payments — averaging $26.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$917
  • Incyte Corporation$739
  • Novartis$521
  • Johnson & Johnson$400
  • Merck$370
  • E.r. Squibb & Sons, L.L.C.$355
  • plus $4K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca12$917
Incyte Corporation19$739
Novartis23$521
Johnson & Johnson15$400
Merck14$370
E.r. Squibb & Sons, L.L.C.18$355
Gilead(2 entities)7$336
Pfizer17$292
Bristol Myers Squibb15$275
Sanofi4$270
Daiichi Sankyo Inc.12$269
AbbVie11$240
Genentech USA, Inc.11$211
Rigel Pharmaceuticals, Inc.4$159
Amgen3$152
Regeneron Healthcare Solutions, Inc.7$150
Eisai Inc.5$109
Lilly USA, LLC4$82
Taiho Oncology, Inc.4$82
Astellas Pharma US Inc4$75
Iovance Biotherapeutics, Inc.2$60
GSK3$59
Takeda Pharmaceuticals U.S.A., Inc.2$56
ADC Therapeutics America, Inc.3$54
Beigene USA, Inc.3$52
Mirati Therapeutics, Inc.3$52
Stemline Therapeutics Inc.2$51
Array Biopharma Inc4$50
Bayer2$48
Jazz Pharmaceuticals Inc.3$47
Beone Medicines USA, Inc.2$39
Sobi, Inc2$39
Acrotech Biopharma Inc.2$38
Puma Biotechnology, Inc.2$38
Pharmacosmos Therapeutics Inc.1$38
Blueprint Medicines Corporation2$38
EMD Serono, Inc.2$34
Legend Biotech USA Inc.1$33
Janssen Scientific Affairs, LLC1$32
Seagen Inc.2$31
Boehringer Ingelheim1$28
Syndax Pharmaceuticals, Inc.1$28
Karyopharm Therapeutics Inc.1$26
Celltrion USA Inc.1$24
Geron Corporation1$22
Morphosys, US Inc.1$22
Genmab U.S., Inc.1$22
AVEO Pharmaceuticals, Inc.1$22
Adaptive Biotechnologies Corporation1$22
Coherus Oncology, Inc.1$21
Cycle Pharmaceuticals Inc1$21
Pharmaessentia USA Corporation1$20
Pharmacyclics LLC, An Abbvie Company1$20
Servier Pharmaceuticals LLC1$20
Sun Pharmaceutical Industries Inc.1$18
Spectrum Pharmaceuticals Inc.1$18
Kyowa Kirin, Inc.1$17
Tempus AI, Inc1$17
Deciphera Pharmaceuticals Inc.1$15
Springworks Therapeutics, Inc.1$14

How this compares

$7,323 in reported general payments places this provider in the 90th percentile of 292 adult health providers in South Carolina.

See all adult health providers in South Carolina →

Medicare billing

Part B allowed, 2024
$98,505
Medicare patients
437
Services billed
4,651

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in West Columbia

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →